Sugi Predict

Sugi Predict / Compounds / SCHEMBL10459265

SCHEMBL10459265

SCHEMBL10459265

CC(C)(CN)CNc1ccc(C(F)(F)F)c(-c2n[nH]c3ncccc23)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 7/20 0.46
▸ CDC7 O00311 6/20 0.46
▸ PIM1 P11309 6/20 0.46
▸ PRKACA P17612 6/20 0.46
▸ HIPK2 Q9H2X6 6/20 0.46
▸ CDK9 P50750 6/20 0.46
▸ ROCK2 O75116 6/20 0.46
▸ MAP4K4 O95819 5/20 0.46
▸ JAK3 P52333 5/20 0.46
▸ CAMK2D Q13557 5/20 0.46
▸ GSK3B P49841 5/20 0.46
▸ DAPK3 O43293 4/20 0.46
▸ PRKD3 O94806 4/20 0.46
▸ PAK4 O96013 4/20 0.46
▸ FLT3 P36888 4/20 0.46
▸ CLK2 P49760 4/20 0.46
▸ CDK7 P50613 4/20 0.46
▸ PRKX P51817 4/20 0.46
▸ CDK5 Q00535 4/20 0.46
▸ MAP4K2 Q12851 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10459336 0.84 CDK2 (0.35) CDK2CDC7PIM1PRKACAHIPK2
SCHEMBL10457569 0.84 CDK2 (0.33) CDK2CDC7PIM1PRKACAHIPK2
SCHEMBL10458838 0.82 CDK2 (0.35) CDK2CDC7PIM1PRKACAHIPK2
SCHEMBL10459320 0.81 ALDH1A1 (0.37) CDK2CDC7PIM1PRKACAHIPK2
SCHEMBL10459366 0.81 PRKCA (0.40) CDK2CDC7PIM1PRKACAHIPK2
SCHEMBL10459237 0.81 PIM1 (0.47) CDK2CDC7PIM1PRKACAHIPK2
SCHEMBL10458869 0.80 MAPK14 (0.36) CDK2CDC7PIM1PRKACAHIPK2
SCHEMBL10458790 0.79 PRKCQ (0.41) CDK2CDC7PIM1PRKACAHIPK2
SCHEMBL10459466 0.78 CDK2 (0.34) CDK2CDC7PIM1PRKACAHIPK2
SCHEMBL10459278 0.78 BCDIN3D (0.35) CDK2CDC7PIM1PRKACAHIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9137973-B2 Pyrazolopyridine kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-09-22 — — US disclosed
US-9137973-B2 Pyrazolopyridine kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-09-22 — — US disclosed
US-9029546-B2 Pyrazolopyridine kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-05-12 — — US disclosed
US-9029546-B2 Pyrazolopyridine kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-05-12 — — US disclosed
US-20140148434-A1 PYRAZOLOPYRIDINE KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-05-29 — — US disclosed
US-20140148434-A1 PYRAZOLOPYRIDINE KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-05-29 — — US disclosed
US-20120184524-A1 PYRAZOLOPYRIDINE KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED 2012-07-19 — — US disclosed
US-20120184524-A1 PYRAZOLOPYRIDINE KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED 2012-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140148434-A1 PYRAZOLOPYRIDINE KINASE INHIBITORS MAP3K5, MAP3K20, MAP3K1 CDK2 77/4885CDC7 421/4885PIM1 220/4885
US-20120184524-A1 PYRAZOLOPYRIDINE KINASE INHIBITORS MAP3K5, MAP3K20, MAP3K1 CDK2 77/4885CDC7 421/4885PIM1 220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.